Michael Shetzline, CMO, SVP, Head-Res&Drug at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 32,256 shares at $6.45 ($208K) on 2024-05-20, disclosed to the SEC on 2024-05-22.
Seasonal sale ($208k) by CMO, SVP, Head-Res&Drug — this insider has traded IRWD in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.45 | 16,128 | $104K | 50.0% |
| 2 | $6.45 | 16,128 | $104K | 50.0% |
| Total | $6.45 avg | 32,256 | $208K | 100% |
| Filing → |
| IRWD | SELL | 2024-02-14 | $1.2M | — | Filing → |
| IRWD | SELL | 2023-05-24 | $209K | — | Filing → |
| IRWD | SELL | 2023-03-01 | $385K | — | Filing → |